A Statement from the NIH Director, Elias A. Zerhouni, M.D., Regarding the 2006 NIH-Supported Presidential Early Career Award for Scientists and Engineers (PECASE) Recipients, November 1, 2007
NIH Grants $33 Million in Institutional Development Awards to Three States, October 29, 2007
NIH Launches Campaign to Raise Awareness of Vulvodynia, a Painful Disorder Affecting Many Women, October 24, 2007
NIH cannot accept donated umbilical cord stem cells from the general public.
This means that embryonic stem cells may be pluripotent—that is, able to give rise to cells found in all tissues of the embryo except for germ cells rather than being merely multipotent—restricted to specific subpopulations of cell types, as adult stem cells are thought to be.
Each organization that receives federal funds on NIH grants and contracts must have in place adequate policies, procedures, and internal controls to provide reasonable assurance that federal funds are not used to support non-federally supported or unallowable costs.
The predecessor of the NIH began in 1887 as the Laboratory of Hygiene.
The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold.
NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information.
Not Invented Here (NIH) is a pejorative term used to describe a persistent corporate or institutional culture that avoids using existing research or knowledge because of its different origins.
The concepts of NIH may be contrasted with the opposite: the Invented Here philosophy.
NIH can be common in the corporate world of Information Technology, and must be compared with technology available at the time.
National Institutes of Health -- Contracts Page(Site not responding. Last check: 2007-11-06)
NIH's acquisitions exceeded $1.7 billion in fiscal year 1997 and involved contract awards to universities, hospitals, state and local government agencies and non-profit and commercial organizations.
All acquisitions at the NIH come under the cognizance of the Principal Official Responsible for Acquisition (PORA) who is the Director of the Office of Contracts Management (OCM).
The responsibility for negotiating, awarding and administering acquisitions rests with the contracting staff in NIH's various Institutes and two central organizations: the Division of Research Contracts, OCM, and the Office of Procurement Management.
A unique aspect of the NIH Roadmap for Medical Research is the NIH Director’s Pioneer Award (NDPA) Program, a high-risk research initiative of Research Teams of the Future.
A group of distinguished outside consultants proposed that NIH implement a completely new program to encourage highly innovative biomedical and behavioral research with the great potential to lead to significant advances in human health.
The NIH Director’s Pioneer Award is among several initiatives being undertaken as a part of the NIH Roadmap.
However, the NIH can and must be a key contributor to solving the obesity problem through scientific research.
Through its research mission, the NIH is seeking to capitalize on recent scientific discoveries to propel new efforts towards further understanding the forces contributing to obesity and towards developing strategies for prevention and treatment.
A key element of the NIH Director's charge to the Task Force is the development of a Strategic Plan for NIH Obesity Research.
NIH is the steward of medical and behavioral research for the nation.
Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability.
Like others in the field, those at the NIH’s main campus in Bethesda, Maryland, and its neighbours in the Washington DC region, are bracing themselves for flat budgets.
GAIT is the first multicenter clinical trial in the United States to test the effects of the dietary supplements glucosamine and chondroitin for treatment of knee osteoarthritis.
On January 27, 1998, NCCAM held a meeting to discuss the need, rationale, and feasibility of conducting a Phase III study (a human study involving over 1,000 patients to test the efficacy, safety, and side effects of a substance[s]) of glucosamine and chondroitin for the treatment of knee osteoarthritis.
The group determined that there was a real and urgent public health need to test these agents in a rigorous way, and that current scientific data supported short-term testing of glucosamine and chondroitin for pain control and functional improvement of osteoarthritis.
This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.
Over the years, the National Institutes of Health (NIH) has funded a variety of research projects on acupuncture, including studies on the mechanisms by which acupuncture may produce its effects, as well as clinical trials and other studies.
To address important issues regarding acupuncture, the NIH Office of Alternative Medicine and the NIH Office of Medical Applications of Research organized a 2-1/2-day conference to evaluate the scientific and medical data on the uses, risks, and benefits of acupuncture procedures for a variety of conditions.
These All About Grants tutorials help biomedical investigators, especially new ones, plan, write, and apply for the basic NIH research project grant, the R01.
Our advice comes from the knowledge and experience of NIAID staff, including former NIH grantees, and should be considered as opinion only.
For other grant types, check the NIH Transition Timeline to see if you should use a paper PHS 398 or electronic Grant Application Package.
CSR - Inside the NIH Grant Review Process(Site not responding. Last check: 2007-11-06)
NIH staff members also volunteered to participate in this video, which was developed in collaboration with the NIH Office of Extramural Research.
This video may be used by individuals, universities, or other organizations without restrictions to advance the understanding of NIH scientific review groups.
Note: These documents were altered to serve as realistic but unidentifiable examples of the documents reviewed and produced by NIH study sections.
The Consortium consists of senior-level representatives from all of the NIH institutes, centers, and divisions plus representatives of other Federal agencies concerned with biomedical research and development.
Impact of Bioengineering at the NIH - Bioengineering is a truly transdisciplinary field that benefits research institutes and centers in their programs to support the NIH's mission of improving the quality of the nation's health by increasing biological knowledge and facilitating the development of novel devices and drugs.
Links to information on NIH policies (technology transfer, intellectual property, commercialization, and sharing of biomedical research resources), and NIH programs associated with biomedical imaging and bioengineering are included.
The NIH Osteoporosis and Related Bone Diseases ~ National Resource Center provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases.
The mission of NIH ORBD~NRC is to expand awareness and enhance knowledge and understanding of the prevention, early detection, and treatment of these diseases as well as strategies for coping with them.
NIH Consensus Development Conference: Osteoporosis Prevention, Diagnosis, and Therapy (2000)
Additional information on the NIH bioengineering funding opportunities can be found at http://www.becon.nih.gov/becon_funding.htm.
While much of biology is grounded in nanoscale phenomena, NIH has not re-classified most of its basic research portfolio as nanotechnology.
NIH participates in the National Nanotechnology Initiative (www.nano.gov), the U.S. federal multi-agency RandD program for nanoscale science, engineering, and technology.
See 08/02/2007 NIH Guide Notice for more information.
The Small Business Innovation Research (SBIR) program is a set-aside program (2.5% of an agency's extramural budget) for domestic small business concerns to engage in Research/Research and Development (R/R&D) that has the potential for commercialization.
Note: It is the applicantâs responsibility to track their application through Grants.gov and NIH eRA Commons.
In partnership with the American Film Institute (AFI) Silver Theatre and Cultural Center, the National Institutes of Health (NIH) Office of Science Education (OSE) is pleased to announce its upcoming film and discussion series,
This popular summer film festival is open to the public and intended for a broad range of individuals who enjoy the cinema and have an interest in science and medicine.
The NIH Clinical Center Pharmacy Department provides pharmaceutical care and research support to patients, health care providers, and investigators.
Pharmacy staff members conduct and participate in research programs that enhance knowledge regarding optimal dosing and appropriate use of investigational and commercially available agents.
Pharmacists at the NIH Clinical Center manage commercially available and investigational drugs in approximately 1,000 research protocols.
www.cc.nih.gov /phar (179 words)
NIMH: NIH-Wide Grants Information(Site not responding. Last check: 2007-11-06)
NIH Grants and Contracts Information and Application Forms
Information on NIH's extramural research and training programs including NIH's funding opportunities (with application kits), grant policy, and award data that includes access to the CRISP database.
This is the main NIH Grants Policy document containing information on NIH grants policy statements, terms and conditions of NIH grant awards, terms and conditions for specific types of grants, grantees, and activities, points of contact, and a master list of links to documents external to the NIHGPS.
NIH Grants $117 Million in Institutional Development Awards to Underserved States The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announces that it will grant $117.3 million to fund four new and seven continuing Centers of Biomedical Research Excellence (COBRE).
The awards support multidisciplinary centers—each concentrating on one general area of research—that strengthen institutional biomedical research capability and enhance research infrastructure.
COBREs are a component of the Institutional Development Award (IDeA) program, designed to improve the competitiveness of investigators in states that historically have not received significant levels of competitive NIH research funding.
NIH News in Health - A monthly newsletter containing practical health information based on research conducted either by NIH's own scientists or by our grantees at universities and medical schools around the country.
CAM at the NIH - A quarterly newsletter produced by the National Center for Complementary and Alternative Medicine (NCCAM), featuring the latest news in CAM research at the NIH.
Connections Newsletter - A quarterly newsletter from the Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging (NIA).
